Ribometrix

Ribometrix

Ribometrix

Ribometrix is a biotechnology company developing small molecule therapeutics that directly target RNA to treat human diseases.
Raised
$37.5M
Follow us
Alexa global traffic share
Twitter followers
Latest funding
$30,000,000
Venture capital (Series A) - 2018
Amgen Ventures Illumina Ventures Pappas Capital +1
Team Size
1–10
Employees
$30,000,000 Venture capital (Series A)
PE HUB

Ribometrix scores $30 mln Series A

FinSMEs , Xconomy

Ribometrix Raises $30M in Series A Funding

$7,500,000 Seed fund
PE HUB

Biotech company Ribometrix snags $7.5 mln seed